Author:
Ingenhoven Theo,Rinne Thomas
Reference78 articles.
1. American Psychiatric Association. (2001). Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association. American Journal of Psychiatry, 158, 1–52.
2. Binks, C., Fenton, M., McCarthy, L., et al. (2006). Pharmacological interventions for people with borderline personality disorder. Cochrane Database System Review, 3, CD005653.
3. Black, D. W., Zanarini, M. C., Romine, A., Shaw, M., Allen, J., & Schulz, S. C. (2014). Comparison of low and moderate dosages of extended-release quetiapine in borderline personality disorder: A randomized, double-blind, placebo-controlled trial. American Journal of Psychiatry, 171(11), 1174–1182.
4. Bogenschutz, M. P., & George, N. H. (2004). Olanzapine versus placebo in the treatment of borderline personality disorder. Journal of Clinical Psychiatry, 65, 104–109.
5. Bouwman, R., Schulze, P. F. J., & Ingenhoven, T. (2013). Shared decision making: Samen kiezen, samen beslissen. Het farmacotherapeutisch spreekuur met borderlinepatiënten. Maandblad voor Geestelijke Volksgezondheid, 68, 208–215.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Persoonlijkheidsstoornissen;Leerboek psychiatrie voor verpleegkundigen;2019-11-22